Zeneca/Astra merger faces FTC investigation

By John Oates, 16 February 1999 15:56

NEWS The merger between pharmaceutical giants Zeneca and Astra has hit a snag in the form of an extended investigation by the US Federal Trade Commission. EU regulators have also asked for an extra two weeks to consider the deal - pushing the deadline back to 1 March. The companies put out a joint statement saying they expected the deal to be approved in the second quarter of this year.

Post your comment

In order to post a comment you need to be registered and logged in.

Log in or create your silicon.com account below

Will not be displayed with your comment

By signing up for this service, you indicate that you agree to our Terms and Conditions and have read and understood our Privacy Policy.

Questions about membership? Find the answers in the Membership FAQ